| 4.005 0.115 (2.96%) | 04-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.13 | 1-year : | 7.18 |
| Resists | First : | 5.25 | Second : | 6.15 |
| Pivot price | 4.97 |
|||
| Supports | First : | 3.79 | Second : | 3.16 |
| MAs | MA(5) : | 4.42 |
MA(20) : | 5.11 |
| MA(100) : | 5.69 |
MA(250) : | 8.11 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 12 |
D(3) : | 20.4 |
| RSI | RSI(14): 30.6  |
|||
| 52-week | High : | 39.59 | Low : | 3.79 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AONC ] has closed above bottom band by 3.3%. Bollinger Bands are 53.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.24 - 4.27 | 4.27 - 4.29 |
| Low: | 3.82 - 3.86 | 3.86 - 3.89 |
| Close: | 3.95 - 4.01 | 4.01 - 4.05 |
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Fri, 19 Apr 2024
American Oncology Network, Inc.'s (NASDAQ:AONC) market cap dropped US$324m last week; Retail investors bore ... - Yahoo News UK
Mon, 01 Apr 2024
American Oncology and Ascend Launch Biotech Analytics Venture - TipRanks.com - TipRanks
Thu, 28 Mar 2024
American Oncology Network, Inc. (AONC) Q4 2023 Earnings Call Transcript - Seeking Alpha
Thu, 28 Mar 2024
American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire
Fri, 22 Mar 2024
These 4 Measures Indicate That American Oncology Network (NASDAQ:AONC) Is Using Debt Extensively - Simply Wall St
Tue, 14 Nov 2023
American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 11 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 49.7 (%) |
| Held by Institutions | 0.6 (%) |
| Shares Short | 26 (K) |
| Shares Short P.Month | 30 (K) |
| EPS | -1.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -0.5 % |
| Operating Margin | -6 % |
| Return on Assets (ttm) | -2.4 % |
| Return on Equity (ttm) | -54.4 % |
| Qtrly Rev. Growth | 7.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 120.64 |
| EBITDA (p.s.) | -0.45 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -18 (M) |
| Levered Free Cash Flow | 19 (M) |
| PE Ratio | -2.95 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.03 |
| Price to Cash Flow | -2.35 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|